Lisata Therapeutics, Inc. (LSTA)

NASDAQ: LSTA · Real-Time Price · USD

3.370

-0.010 (-0.29%)

At close: Jun 26, 2026, 4:00 PM EDT

3.360

-0.010 (-0.30%)

After-hours: Jun 26, 2026, 4:10 PM EDT

Lisata Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Lisata Therapeutics.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

The average analyst rating for Lisata Therapeutics stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jul '25	Aug '25	Nov '25	Jan '26	Mar '26	May '26
Strong Buy	1	2	2	1	0	0
Buy	2	1	1	1	1	0
Hold	0	0	0	1	1	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	May 18, 2026
Kemp Dolliver Brookline Capital Markets	Brookline Capital Markets	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jan 21, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 170.00K

-100.00%

from 170.00K

Revenue Next Year

n/a

EPS This Year

-1.09

from -1.91

EPS Next Year

-1.16

from -1.09

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	1.00M	170.00K	-	-
Revenue Growth	-	-	-	-	-83.00%	-100.00%	-
EPS	-7.45	-10.47	-2.58	-2.40	-1.91	-1.09	-1.16
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	1	1

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-100.0%	-
Avg	-100.0%	-
Low	-100.0%	-

EPS Forecast

EPS	2026	2027
High	-	-
Avg	-1.09	-1.16
Low	-	-

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.